Thomas C. Rindflesch
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas C. Rindflesch.
Journal of Biomedical Informatics | 2014
Rui Zhang; Michael J. Cairelli; Marcelo Fiszman; Graciela Rosemblat; Halil Kilicoglu; Thomas C. Rindflesch; Serguei V. S. Pakhomov; Genevieve B. Melton
In this study we report on potential drug-drug interactions between drugs occurring in patient clinical data. Results are based on relationships in SemMedDB, a database of structured knowledge extracted from all MEDLINE citations (titles and abstracts) using SemRep. The core of our methodology is to construct two potential drug-drug interaction schemas, based on relationships extracted from SemMedDB. In the first schema, Drug1 and Drug2 interact through Drug1s effect on some gene, which in turn affects Drug2. In the second, Drug1 affects Gene1, while Drug2 affects Gene2. Gene1 and Gene2, together, then have an effect on some biological function. After checking each drug pair from the medication lists of each of 22 patients, we found 19 known and 62 unknown drug-drug interactions using both schemas. For example, our results suggest that the interaction of Lisinopril, an ACE inhibitor commonly prescribed for hypertension, and the antidepressant sertraline can potentially increase the likelihood and possibly the severity of psoriasis. We also assessed the relationships extracted by SemRep from a linguistic perspective and found that the precision of SemRep was 0.58 for 300 randomly selected sentences from MEDLINE. Our study demonstrates that the use of structured knowledge in the form of relationships from the biomedical literature can support the discovery of potential drug-drug interactions occurring in patient clinical data. Moreover, SemMedDB provides a good knowledge resource for expanding the range of drugs, genes, and biological functions considered as elements in various drug-drug interaction pathways.
CPT Pharmacometrics Syst. Pharmacol. | 2014
Trevor Cohen; Dominic Widdows; C Stephan; R Zinner; J Kim; Thomas C. Rindflesch; P Davies
The identification of new therapeutic uses for existing agents has been proposed as a means to mitigate the escalating cost of drug development. A common approach to such repurposing involves screening libraries of agents for activities against cell lines. In silico methods using knowledge from the biomedical literature have been proposed to constrain the costs of screening by identifying agents that are likely to be effective a priori. However, results obtained with these methods are seldom evaluated empirically. Conversely, screening experiments have been criticized for their inability to reveal the biological basis of their results. In this paper, we evaluate the ability of a scalable literature‐based approach, discovery‐by‐analogy, to identify a small number of active agents within a large library screened for activity against prostate cancer cells. The methods used permit retrieval of the knowledge used to infer their predictions, providing a plausible biological basis for predicted activity.
Journal of Biomedical Informatics | 2013
Graciela Rosemblat; Dongwook Shin; Halil Kilicoglu; Charles Sneiderman; Thomas C. Rindflesch
We describe a domain-independent methodology to extend SemRep coverage beyond the biomedical domain. SemRep, a natural language processing application originally designed for biomedical texts, uses the knowledge sources provided by the Unified Medical Language System (UMLS©). Ontological and terminological extensions to the system are needed in order to support other areas of knowledge. We extended SemReps application by developing a semantic representation of a previously unsupported domain. This was achieved by adapting well-known ontology engineering phases and integrating them with the UMLS knowledge sources on which SemRep crucially depends. While the process to extend SemRep coverage has been successfully applied in earlier projects, this paper presents in detail the step-wise approach we followed and the mechanisms implemented. A case study in the field of medical informatics illustrates how the ontology engineering phases have been adapted for optimal integration with the UMLS. We provide qualitative and quantitative results, which indicate the validity and usefulness of our methodology.
Cancer Informatics | 2014
Rui Zhang; Michael J. Cairelli; Marcelo Fiszman; Halil Kilicoglu; Thomas C. Rindflesch; Serguei V. S. Pakhomov; Genevieve B. Melton
In this study, we report on the performance of an automated approach to discovery of potential prostate cancer drugs from the biomedical literature. We used the semantic relationships in SemMedDB, a database of structured knowledge extracted from all MEDLINE citations using SemRep, to extract potential relationships using knowledge of cancer drugs pathways. Two cancer drugs pathway schemas were constructed using these relationships extracted from SemMedDB. Trough both pathway schemas, we found drugs already used for prostate cancer therapy and drugs not currently listed as the prostate cancer medications. Our study demonstrates that the appropriate linking of relevant structured semantic relationships stored in SemMedDB can support the discovery of potential prostate cancer drugs.
international conference on computational linguistics | 1986
Michael B. Kac; Thomas C. Rindflesch; Karen L. Ryan
In this paper wc will describe an approach to parsing one major component of which is a stragegy called RECONNAISSANCEATTACK. Under this strategy, no structure building is attempted until after completion of a preliminary phase designed to exploit low-level information to the fullest possible extent. This first pass then defines a set of constraints that restrict the set of available options when structure building proper begins. R-A parsing is in principle compatible with a variety of different views regarding the nature of syntactic representation, though it fits more comfortably with some than with others--a point to which we shall return.
Language Sciences | 1992
Thomas C. Rindflesch; Jennifer E. Reeves; Michael B. Kac
Abstract We reexamine data from Caplan and Hildebrandt 1988 within the context of a different set of background assumptions, concluding that where these can be clearly distinguished from those underlying GB theory the evidence favors a non-GB-based account. We attribute the deficits observed in the process of infinitival complement constructions to an inability on the part of the patients to access either or both of two data structures required to support our proposed parsing algorithm, and show that on this account it is unnecessary to posit a compensatory heuristic to account for the behavior observed. We also question some other cases where Caplan and Hildebrandt advert to compensatory heuristics.
Journal of Biomedical Informatics | 2014
Ning Shang; Hua Xu; Thomas C. Rindflesch; Trevor Cohen
american medical informatics association annual symposium | 2013
Michael J. Cairelli; Christopher M. Miller; Marcelo Fiszman; Terri Elizabeth Workman; Thomas C. Rindflesch
american medical informatics association annual symposium | 2013
Terri Elizabeth Workman; Graciela Rosemblat; Marcelo Fiszman; Thomas C. Rindflesch
medical informatics europe | 2014
Andrej Kastrin; Thomas C. Rindflesch; Dimitar Hristovski